allogeneic mesenchymal stem cells: Clinical Trials

10 trials of allogeneic mesenchymal stem cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 active not recruiting, 1 recruiting. 7 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 6, Active not recruiting 1
Phase 14Completed 2, Active not recruiting 1, Recruiting 1

Follow allogeneic mesenchymal stem cells: new trials by email Literature Review of allogeneic mesenchymal stem cells trials Research Report on allogeneic mesenchymal stem cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Allogeneic Use of Expanded Mesenchymal Stem Cells Derived From Adipose Tissue (HC106), Female Urinary Incontinence Women Over 50 Years Old
allogeneic mesenchymal stem cells, Placebo - Urinary Incontinence Stress
Phase 1RecruitingInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz602024-12-162025-05-01
Stem Cell and Conditioned Medium for Cerebral Palsy
Umbilical Cord Mesenchymal Stem Cells, Conditioned Medium, Standard Therapy - Cerebral Palsy
Phase 1 / Phase 2Active not recruitingPT. Prodia Stem Cell Indonesia782021-10-132026-02-25
Phase IIa Randomized Placebo Controlled Trial: Mesenchymal Stem Cells as a Disease-modifying Therapy for Idiopathic Parkinson's Disease
Mesenchymal Stem Cells, Placebo - Parkinson's Disease
Phase 2CompletedMya Schiess452020-11-092026-09-02
Stem Cell Injection in Cancer Survivors
Allo-MSCs, Placebo - Cardiomyopathy Due to Anthracyclines
Phase 1CompletedThe University of Texas Health Science Center, Houston462016-08-012020-11-05
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial
ALLO-ASC-DFU, Standard therapy - Diabetic Foot Ulcer
CompletedAnterogen Co., Ltd.542015-12-292023-08-25
A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects
ALLO-ASC-DFU, Conventional Therapy - Burn Injury
Phase 2CompletedAnterogen Co., Ltd.202015-12-232023-08-25
Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
Allogeneic mesenchymal stem cells, Polyurethene Film - Dystrophic Epidermolysis Bullosa
Phase 1 / Phase 2CompletedAnterogen Co., Ltd.22015-12-082023-08-25
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers
ALLO-ASC-DFU, Standard therapy - Diabetic Foot Ulcer
Phase 2CompletedAnterogen Co., Ltd.592015-10-012017-09-01
Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis
Allogeneic Mesenchymal Stem Cells - Alcoholic Liver Cirrhosis
Phase 2CompletedStempeutics Research Pvt Ltd402012-06-012016-09-15
A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease
Allogeneic Mesenchymal Stem Cells - Critical Limb Ischemia, Buerger's Disease
Phase 2CompletedStempeutics Research Pvt Ltd902012-01-012016-09-13

Conditions studied

Diabetic Foot (2)  ·  Breast Neoplasms (1)  ·  Burns (1)  ·  Cardiomyopathies (1)  ·  Cerebral Palsy (1)  ·  Chronic Limb-Threatening Ischemia (1)  ·  Epidermolysis Bullosa (1)  ·  Epidermolysis Bullosa Dystrophica (1)  ·  Fibrosis (1)  ·  Leukemia (1)  ·  Liver Cirrhosis, Alcoholic (1)  ·  Lymphoma (1)  ·  Parkinson Disease (1)  ·  Sarcoma (1)  ·  Thromboangiitis Obliterans (1)

Sponsors

Anterogen Co., Ltd. (4)  ·  Stempeutics Research Pvt Ltd (2)  ·  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1)  ·  Mya Schiess (1)  ·  PT. Prodia Stem Cell Indonesia (1)  ·  The University of Texas Health Science Center, Houston (1)

Countries

South Korea (4)  ·  India (2)  ·  United States (2)  ·  Indonesia (1)  ·  Spain (1)

Top investigators

Dr Alfred Augustine (1)  ·  Dr Anirban Chatterjee (1)  ·  Dr Anita Dhar (1)  ·  Dr Murali Krishna (1)  ·  Dr Radhakrishnan R (1)  ·  Dr Rajiv Parakh (1)  ·  Dr Rajkumar M (1)  ·  Dr Sandeep Nijhwan Nijhwan, MD., DM (1)  ·  Dr Sanjay Desai (1)  ·  Dr Sanjay Kolte Kolte, DNB., FCPS (1)  ·  Dr Santanu Dutta (1)  ·  Dr Uma Devi, MD (1)  ·  Dr Vidyasagaran T (1)  ·  Dr. Aejaz Habeeb, MD., DM (1)

Results publications

PMID 30679183, PMID 40993774

NIH funding

5UM1HL087318 (1)